Cafepharma Today

February 21 2025 - Teva Pharma and Alvotech launch US biosimilar to J&J's Stelara
Teva Pharma and Alvotech launch US biosimilar to J&J's Stelara
Device industry scrambles amid concern FDA layoffs will cause delays
Shortage of Novo’s Wegovy and Ozempic is resolved, FDA website shows
Bluebird, at risk of default, agrees to take-private deal
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Abbott Tries a Crash Diet
Motley Fool
Friday, August 22, 2008 - 4:27pm
tags:
Amgen's Nplate Approved by U.S. for Bleeding Disorder
Bloomberg
Friday, August 22, 2008 - 3:18pm
tags:
Alpharma shares surge on King buyout offer
Forbes
Friday, August 22, 2008 - 3:17pm
tags:
Genentech Ditches Stock Options to Fund $371 Million Retention Plan
WSJ Online
Friday, August 22, 2008 - 10:02am
tags:
Merger Watch: APP Pharmaceuticals - Fresenius
Seeking Alpha
Friday, August 22, 2008 - 10:01am
tags:
Onyx and Bayer say patients are enrolling in trial of Nexavar for liver cancer
Yahoo/AP
Friday, August 22, 2008 - 9:39am
tags:
Eli Lilly's Cymbalta gets expanded European approval as anxiety disorder treatment
Yahoo/AP
Friday, August 22, 2008 - 9:36am
tags:
Fresenius Stays Strong in Tough Times
Businessweek
Friday, August 22, 2008 - 9:34am
tags:
FDA: Vytorin Not Linked to Cancer Risk
WSJ Online
Friday, August 22, 2008 - 9:33am
tags:
King Pharmaceuticals Bids $1.38 Billion for Alpharma
Bloomberg
Friday, August 22, 2008 - 9:30am
tags:
The Genentech Guessing Game - What Will Roche Offer Next?
Seeking Alpha
Thursday, August 21, 2008 - 9:02pm
tags:
DNA analysis heralds a health care revolution
Fortune
Thursday, August 21, 2008 - 9:01pm
tags:
PDL BioPharma's Partnership Makes Sense
Motley Fool
Thursday, August 21, 2008 - 5:54pm
tags:
Johnson & Johnson Gets Rejected
Motley Fool
Thursday, August 21, 2008 - 5:50pm
tags:
Congressmen demand Merck, Schering-Plough supply info on possible Vytorin cancer risk
Yahoo/AP
Thursday, August 21, 2008 - 5:34pm
tags:
A Gardasil Gotcha
Motley Fool
Thursday, August 21, 2008 - 5:22pm
tags:
For Abbott, Diversity Remains Paramount
Yahoo/TheStreet.com
Thursday, August 21, 2008 - 5:18pm
tags:
Abbott to cut 1,000 jobs from diagnostic unit
Yahoo/AP
Thursday, August 21, 2008 - 5:14pm
tags:
Genzyme, PTC Therapeutics Cystic Fibrosis Drug Relieves Symptom
Bloomberg
Thursday, August 21, 2008 - 12:07pm
tags:
Bristol-Myers Ponies Up for Elotuzumab
Seeking Alpha
Thursday, August 21, 2008 - 12:06pm
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Pharma CEOS Speaking Up, Damn It
In the Pipeline
So Why Don't Antibiotics Always Work?
In the Pipeline
Vanishing Act: Why Small Pharmacies Exited Medicare Part D Networks for 2025
Drug Channels
The Continuing Crisis, Part IV
In the Pipeline
Compliance is Futile Without Transparency: 340B, MDRP, MFP Overlap Lead to Iceberg Ahead
Drug Channels
AI Antibodies? Really?
In the Pipeline
Stand Up And Be Counted
In the Pipeline
Why Plan Sponsors and PBMs Are Still Falling Hard for Copay Maximizers
Drug Channels
Huntington's Disease, Cell by Cell
In the Pipeline

Latest Jobs

Area Manager, Specialty Chicago
Fields, Oregon, 97710
CSL Behring
Area Manager-Specialty Northeast, Albany
Fields, Oregon, 97710
CSL Behring
Psychiatry Account Manager - Carbondale, IL
Carbondale, Illinois, 62901
Lundbeck
Business Development Specialist
Bradenton, Florida, 34205
Professional Case Management
Business Development Specialist
Sarasota, Florida, 34243
Professional Case Management
Manager Coagulation Products, Plains
Fields, Oregon, 97710
CSL Behring
Area Manager, Immunology Sales Minneapolis, MN
Coffeyville, Kansas, 67337
CSL Behring
Clinical Account Executive
Oakwood Village, Ohio
SOFIE
Area Manager-Specialty North Central
Fields, Oregon, 97710
CSL Behring
Community Outreach Marketing Specialist
Stanford, California, California, 94305
Stanford University
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information